187 related articles for article (PubMed ID: 38788817)
1. Role of tumor-derived exosomes mediated immune cell reprograming in cancer.
Liu Z; Chen Z; Zhang J; Liu J; Li B; Zhang Z; Cai M; Zhang Z
Gene; 2024 Oct; 925():148601. PubMed ID: 38788817
[TBL] [Abstract][Full Text] [Related]
2. The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells.
Hosseini R; Asef-Kabiri L; Yousefi H; Sarvnaz H; Salehi M; Akbari ME; Eskandari N
Mol Cancer; 2021 Jun; 20(1):83. PubMed ID: 34078376
[TBL] [Abstract][Full Text] [Related]
3. Exosome-Mediated Immunosuppression in Tumor Microenvironments.
Xie QH; Zheng JQ; Ding JY; Wu YF; Liu L; Yu ZL; Chen G
Cells; 2022 Jun; 11(12):. PubMed ID: 35741075
[TBL] [Abstract][Full Text] [Related]
4. NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment.
Russo E; Laffranchi M; Tomaipitinca L; Del Prete A; Santoni A; Sozzani S; Bernardini G
Front Immunol; 2021; 12():787116. PubMed ID: 34975880
[TBL] [Abstract][Full Text] [Related]
5. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.
Lu M; Huang B; Hanash SM; Onuchic JN; Ben-Jacob E
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4165-74. PubMed ID: 25246552
[TBL] [Abstract][Full Text] [Related]
6. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy.
Hosseini R; Sarvnaz H; Arabpour M; Ramshe SM; Asef-Kabiri L; Yousefi H; Akbari ME; Eskandari N
Mol Cancer; 2022 Jan; 21(1):15. PubMed ID: 35031075
[TBL] [Abstract][Full Text] [Related]
7.
Zeng W; Yin X; Jiang Y; Jin L; Liang W
STAR Protoc; 2021 Mar; 2(1):100361. PubMed ID: 33786458
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
Front Immunol; 2020; 11():631713. PubMed ID: 33679726
[TBL] [Abstract][Full Text] [Related]
9. Exosomes as mediators of immune regulation and immunotherapy in cancer.
Kugeratski FG; Kalluri R
FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
[TBL] [Abstract][Full Text] [Related]
10. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
11. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.
Jacobs B; Gebel V; Heger L; Grèze V; Schild H; Dudziak D; Ullrich E
Front Immunol; 2021; 12():670540. PubMed ID: 34054844
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
Fanini F; Fabbri M
Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
14. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J
Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082
[TBL] [Abstract][Full Text] [Related]
15. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?
Jacobs B; Ullrich E
Curr Med Chem; 2012; 19(12):1771-9. PubMed ID: 22414086
[TBL] [Abstract][Full Text] [Related]
16. New insights into the biological impacts of immune cell-derived exosomes within the tumor environment.
Shen M; Ren X
Cancer Lett; 2018 Sep; 431():115-122. PubMed ID: 29857125
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
18. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
Rashid MH; Borin TF; Ara R; Piranlioglu R; Achyut BR; Korkaya H; Liu Y; Arbab AS
Oncol Rep; 2021 Mar; 45(3):1171-1181. PubMed ID: 33469683
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived exosomes induce CD8
Maybruck BT; Pfannenstiel LW; Diaz-Montero M; Gastman BR
J Immunother Cancer; 2017 Aug; 5(1):65. PubMed ID: 28806909
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived exosomes (TDEs): How to avoid the sting in the tail.
Wan M; Ning B; Spiegel S; Lyon CJ; Hu TY
Med Res Rev; 2020 Jan; 40(1):385-412. PubMed ID: 31318078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
